Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems

被引：87

作者：

Carlsson, A ^{[1
]}

机构：

[1] Univ Gothenburg, Dept Pharmacol, SE-40530 Gothenburg, Sweden

来源：

JOURNAL OF NEURAL TRANSMISSION | 2002年 / 109卷 / 5-6期

关键词：

D O I：

10.1007/s007020200064

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：777 / 787

页数：11

共 38 条

[1] ADRENERGIC MECHANISMS [J].

ANDEN, NE ;

CARLSSON, A ;

HAGGENDAL, J .

ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :119-+

[2]

ANDEN NE, 1970, ACTA MED SCAND, V187, P247

[3]

Barbeau A., 1962, MONOAMINES SYSTEME N, P247

[4] OCCURRENCE AND DISTRIBUTION OF DOPAMINE IN BRAIN AND OTHER TISSUES [J].

BERTLER, A ;

ROSENGREN, E .

EXPERIENTIA, 1959, 15 (01) :10-11

[5]

BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[6] Network interactions in schizophrenia - therapeutic implications [J].

Carlsson, A ;

Waters, N ;

Waters, S ;

Carlsson, ML .

BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :342-349

[7]

CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140

[8]

CARLSSON A, 1959, PHARMACOL REV, V11, P490

[9] PRESENCE OF 3-HYDROXYTYRAMINE IN BRAIN [J].

CARLSSON, A ;

LINDQVIST, M ;

MAGNUSSON, T ;

WALDECK, B .

SCIENCE, 1958, 127 (3296) :471-471

[10] 3,4-DIHYDROXYPHENYLALANINE AND 5-HYDROXYTRYPTOPHAN AS RESERPINE ANTAGONISTS [J].

CARLSSON, A ;

LINDQVIST, M ;

MAGNUSSON, T .

NATURE, 1957, 180 (4596) :1200-1200

← 1 2 3 4 →